Beta Bionics (BBNX) Competitors $13.52 -0.62 (-4.38%) As of 07/3/2025 01:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BBNX vs. LIVN, WRBY, NVCR, LMAT, ENOV, EYE, CNMD, AORT, TNDM, and CDREShould you be buying Beta Bionics stock or one of its competitors? The main competitors of Beta Bionics include LivaNova (LIVN), Warby Parker (WRBY), NovoCure (NVCR), LeMaitre Vascular (LMAT), Enovis (ENOV), National Vision (EYE), CONMED (CNMD), Artivion (AORT), Tandem Diabetes Care (TNDM), and Cadre (CDRE). These companies are all part of the "medical equipment" industry. Beta Bionics vs. Its Competitors LivaNova Warby Parker NovoCure LeMaitre Vascular Enovis National Vision CONMED Artivion Tandem Diabetes Care Cadre Beta Bionics (NASDAQ:BBNX) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, analyst recommendations and risk. Do analysts recommend BBNX or LIVN? Beta Bionics presently has a consensus target price of $23.44, suggesting a potential upside of 73.41%. LivaNova has a consensus target price of $59.29, suggesting a potential upside of 28.52%. Given Beta Bionics' higher probable upside, research analysts clearly believe Beta Bionics is more favorable than LivaNova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beta Bionics 0 Sell rating(s) 4 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.75LivaNova 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of BBNX or LIVN? 97.6% of LivaNova shares are held by institutional investors. 0.3% of LivaNova shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media favor BBNX or LIVN? In the previous week, Beta Bionics had 6 more articles in the media than LivaNova. MarketBeat recorded 8 mentions for Beta Bionics and 2 mentions for LivaNova. LivaNova's average media sentiment score of 1.76 beat Beta Bionics' score of 0.33 indicating that LivaNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beta Bionics 1 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral LivaNova 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is BBNX or LIVN more profitable? Beta Bionics has a net margin of 0.00% compared to LivaNova's net margin of -17.41%. LivaNova's return on equity of 13.67% beat Beta Bionics' return on equity.Company Net Margins Return on Equity Return on Assets Beta BionicsN/A N/A N/A LivaNova -17.41%13.67%6.68% Which has higher valuation and earnings, BBNX or LIVN? LivaNova has higher revenue and earnings than Beta Bionics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeta Bionics$65.12M9.00-$54.76MN/AN/ALivaNova$1.25B2.01$63.23M-$4.09-11.28 SummaryLivaNova beats Beta Bionics on 8 of the 13 factors compared between the two stocks. Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BBNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBNX vs. The Competition Export to ExcelMetricBeta BionicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$586.18M$6.86B$5.53B$9.05BDividend YieldN/A1.21%5.24%4.03%P/E RatioN/A26.1527.5220.22Price / Sales9.0099.70421.02118.64Price / CashN/A21.0936.8958.07Price / Book-2.364.748.045.67Net Income-$54.76M$173.18M$3.18B$249.13M7 Day Performance-10.29%1.33%2.90%3.28%1 Month Performance-30.84%0.16%3.70%5.55%1 Year PerformanceN/A23.71%36.15%21.12% Beta Bionics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBNXBeta BionicsN/A$13.52-4.4%$23.44+73.4%N/A$586.18M$65.12M0.00294Gap UpLIVNLivaNova3.2426 of 5 stars$45.80-0.2%$59.29+29.4%-12.6%$2.50B$1.25B-11.202,900News CoverageWRBYWarby Parker2.2282 of 5 stars$21.51-1.3%$22.88+6.4%+37.1%$2.28B$771.32M-179.233,780NVCRNovoCure3.6878 of 5 stars$17.10-1.3%$32.83+92.0%+4.9%$1.93B$605.22M-11.321,488LMATLeMaitre Vascular2.7158 of 5 stars$82.40-2.5%$97.83+18.7%+3.8%$1.91B$219.86M41.62490Positive NewsENOVEnovis3.549 of 5 stars$32.28+0.5%$58.00+79.7%-24.3%$1.84B$2.11B-2.317,367Positive NewsEYENational Vision2.652 of 5 stars$23.06+0.0%$18.67-19.1%+92.2%$1.82B$1.82B-69.8813,411Positive NewsHigh Trading VolumeCNMDCONMED4.6557 of 5 stars$52.36-0.1%$62.20+18.8%-19.5%$1.62B$1.31B13.783,900Positive NewsAORTArtivion2.4992 of 5 stars$30.58-0.1%$32.00+4.7%+18.8%$1.31B$388.54M-61.151,600TNDMTandem Diabetes Care4.2181 of 5 stars$19.11-1.6%$33.43+74.9%-57.1%$1.29B$940.20M-6.872,650Positive NewsCDRECadre3.6812 of 5 stars$32.23+1.9%$37.50+16.4%-5.3%$1.29B$567.56M33.922,284 Related Companies and Tools Related Companies LivaNova Competitors Warby Parker Competitors NovoCure Competitors LeMaitre Vascular Competitors Enovis Competitors National Vision Competitors CONMED Competitors Artivion Competitors Tandem Diabetes Care Competitors Cadre Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BBNX) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
